# Stem Cell Transplantation for Patients With Hematologic Malignancies

> **NCT00152139** · PHASE3 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 33 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemias
- Acute Myelocytic Leukemia
- Chronic Myeloid Leukemia
- Juvenile Myelomonocytic Leukemia
- Myelodysplastic Syndrome
- Hemoglobinuria, Paroxysmal
- Non-Hodgkin Lymphoma

## Interventions

- **PROCEDURE:** Allogeneic Stem Cell Transplantation
- **DRUG:** Chemotherapy and antibodies

## Key facts

- **NCT ID:** NCT00152139
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2005-06
- **Final completion:** 2009-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2009-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152139, "Stem Cell Transplantation for Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00152139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*